0001144204-19-040420.txt : 20190816
0001144204-19-040420.hdr.sgml : 20190816
20190816162337
ACCESSION NUMBER: 0001144204-19-040420
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190816
FILED AS OF DATE: 20190816
DATE AS OF CHANGE: 20190816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Capponi Vincent
CENTRAL INDEX KEY: 0001368151
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36792
FILM NUMBER: 191033757
MAIL ADDRESS:
STREET 1: MEDASORB TECHNOLOGIES
STREET 2: 7 DEER PARK DRIVE, SUITE K
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cytosorbents Corp
CENTRAL INDEX KEY: 0001175151
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 980373793
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7 DEER PARK DRIVE, SUITE K
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
BUSINESS PHONE: 973-329-8885
MAIL ADDRESS:
STREET 1: 7 DEER PARK DRIVE, SUITE K
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
FORMER COMPANY:
FORMER CONFORMED NAME: MedaSorb Technologies CORP
DATE OF NAME CHANGE: 20060807
FORMER COMPANY:
FORMER CONFORMED NAME: GILDER ENTERPRISES INC
DATE OF NAME CHANGE: 20020611
4
1
tv527862_4.xml
OWNERSHIP DOCUMENT
X0306
4
2019-08-16
0
0001175151
Cytosorbents Corp
CTSO
0001368151
Capponi Vincent
C/O CYTOSORBENTS CORPORATION
7 DEER PARK DRIVE, SUITE K
MONMOUTH JUNCTION
NJ
08852
0
1
0
0
Chief Operating Officer
Common Stock
2019-08-16
4
M
0
4600
4.325
A
372501
D
Stock Option (right to buy)
4.325
2019-08-16
4
M
0
4600
0
D
2020-01-04
Common Stock
4600
15400
D
Includes (i) the following restricted stock units ("RSUs") that will be settled into common stock upon vesting upon a "Change In Control" of the issuer as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 10,100 RSUs granted on March 15, 2018, (b) 17,900 RSUs granted on February 24, 2017, (c) 54,000 RSUs granted on June 7, 2016 and (d) 125,000 RSUs granted on April 8, 2015; (ii) the following RSUs subject to vesting in three equal annual installments with the first of such vesting beginning on the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting: (a) 36,067 RSUs granted on July 22, 2019 and unvested as of the date hereof,
(b) 3,080 granted on March 4, 2019 and unvested as of the date hereof and (c) 12,667 RSUs granted on February 28, 2018 and unvested as of the date hereof; and (iii) 113,687 shares of common stock owned by the reporting person, inclusive of the 4,600 shares of common stock reported on this Form 4.
The option, representing a right to purchase a total of 20,000 shares of common stock (after giving effect to the issuer's twenty-five-for-one reverse split) became exercisable in five equal annual installments, with the first installment vesting on the date of grant.
/s/ Kathleen P. Bloch attorney-in-fact for Vincent Capponi
2019-08-16